Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis von Kondo, Masahiro, Suzuki, Tsuyoshi, Kawano, Yuko, Kojima, Shinji, Miyashiro, Masahiko, Matsumoto, Atsuhiro, Kania, Gabriela, Błyszczuk, Przemysław, Ross, Rebecca L., Mulipa, Panji, Galdo, Francesco Del, Zhang, Yun, Distler, Jörg H. W.

kostenfrei
kostenfrei